Acorda Therapeutics

$3.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-2.63%) Today
-$0.11 (-2.70%) As of 8:49 PM UTC after-hours

Why Robinhood?

You can buy or sell ACOR and other stocks, options, and ETFs commission-free!

About ACOR

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene).

CEO
Ronald Cohen
Employees
168
Headquarters
Ardsley, New York
Founded
1995
Market Cap
41.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
179.40K
High Today
$4.22
Low Today
$3.91
Open Price
$4.21
Volume
224.39K
52 Week High
$9.84
52 Week Low
$2.53

ACOR Earnings

-$1.06
-$0.71
-$0.35
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours

You May Also Like

MSVB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure